NRIX
Nurix Therapeutics, Inc.
Set alert
26.80 USD -0.32 -1.18%
25.97 Day range 26.92
12.17 52-week range 27.79
- YTD
- +41.28%
- 1 year
- +109.70%
- Open
- 26.90
- Prev close
- 27.12
- Mkt cap
- 2.93B
- Vol
- 2.31M
- Avg vol
- 1.70M
- EPS
- 2.43
- P/E
- 11.03
- Div yield
- 0.00%
More statistics
- Low
- 25.97
- High
- 26.92
- Forward P/E
- -21.01
- Beta
- 1.82
- Short ratio
- 10.30
- Inst. own
- 109.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 27, 2027
- 50-d avg
- 24.99
- 200-d avg
- 20.14
- 1y target
- 34.50
1Y chart
Closing price and volume
Compare NRIX
Chart and line up NRIX against other symbols or a saved comparison set.
- NRIX Nurix Therapeutics, Inc.
26.80
-0.32 -1.18%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | NRIX | SPY | QQQ |
|---|---|---|---|
| Last price | 26.80 | 755.72 | 690.49 |
| Change | -0.32 | -13.64 | -24.85 |
| Change % | -1.18% | -1.77% | -3.47% |
| Open | 26.90 | 761.38 | 697.13 |
| Day high | 26.92 | 761.46 | 698.63 |
| Day low | 25.97 | 750.36 | 683.45 |
| Previous close | 27.12 | 769.36 | 715.34 |
| Volume | 2.31M | 77.70M | 85.24M |
| Average volume | 1.70M | 41.22M | 34.57M |
| Market cap | 2.93B | 812.08B | 483.28B |
| P/E ratio | 11.03 | 23.99 | 26.44 |
| Earnings per share | 2.43 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 27.79 | 779.09 | 759.66 |
| 52-week low | 12.17 | 631.97 | 558.28 |
| 1-week return | +5.76% | -0.559233% | -1.97% |
| 1-month return | +13.03% | -0.906075% | -6.66% |
| 3-month return | +13.66% | +1.89% | +1.02% |
| 6-month return | +60.48% | +5.16% | +3.41% |
| Year-to-date return | +41.28% | +10.82% | +12.40% |
| 1-year return | +109.70% | +11.16% | +10.29% |
| 2-year return | +9.03% | +32.90% | +42.71% |
| 50-day moving average | 24.99 | 767.63 | 725.41 |
| 200-day moving average | 20.14 | 728.53 | 679.17 |
| Target price | 34.50 | — | — |
| Beta | 1.82 | 0.00 | 0.00 |
| Short ratio | 10.30 | — | — |
| Institutional ownership | 109.41% | — | — |